arrow
M

M K Javaid

University of Oxford
H指数:75
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Brittle Bone Society best practice management recommendations for adults with severe Osteogenesis Imperfecta (OI), including type III OI: a consensus statement from a multi-disciplinary severe OI working group

英国脆骨病协会关于成人严重型成骨不全(包括III型成骨不全)的最佳管理实践建议:来自多学科严重型成骨不全工作组的一致性声明

2026-09-080
OA
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta

TOPaZ研究基线特征:特立帕肽和唑来膦酸与标准护理在成骨不全成人中的随机对照试验

2025-11-080
OAAI
Developing a Standardised Dataset for Natural History Studies in Fibrous Dysplasia/McCune-Albright Syndrome
2025-05-020
OAAI
Current Practices in Monitoring Children and Adults With X-linked Hypophosphatemia: A Global Survey of Expert Experience

X-连锁低磷酸盐血症儿童和成人监测的当前实践:一项全球专家经验调查

2025-03-201
OA
XLH Matters: an evolving programme to discuss new advances and share clinical experiences to improve patient outcomes
2025-02-030
OAAI
Secure: A Prospective Long-Term Observational Study in Patients with Monoclonal Gammopathy of Undetermined Significance

安全:一项前瞻性长期观察研究,研究对象为意义未明的单克隆丙种球蛋白病患者

BLOOD
IF23.1
2024-11-050
PRE
Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study

Settrusumab用于治疗成骨不全症: 2b期小行星研究的12个月结果

2024-07-168
PRE
Following hip fracture, hospital organizational factors associated with prescription of anti-osteoporosis medication on discharge, to address imminent refracture risk: a record-linkage study

髋部骨折后,与出院时抗骨质疏松药物处方相关的医院组织因素,以解决迫在眉睫的再骨折风险: 一项记录链接研究

2024-07-111
OAAI
HEALTH-RELATED QUALITY OF LIFE IN ANTENATAL WOMEN WITH RHEUMATIC DISEASES: INSIGHTS USING PROMIS INSTRUMENTS FROM THE COVAD 2 DATASET

与妊娠相关的生命质量在患有风湿性疾病孕妇中的研究:利用PROMIS量表从COVAD 2数据集中获得的见解

2024-06-010
PRE